Topic archive

u.s. drug enforcement administration

3 stories

10/5/2026

Psyence partners with Benuvia for ibogaine production

DEA-registered Benuvia to manufacture ibogaine for Psyence in the U.S.

8/21/2026

Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.

8/18/2026

Ibogaine remains illegal in the US despite its potential therapeutic benefits.